Cognyte Software (CGNT) News Today

Cognyte Software Ltd. (NASDAQ:CGNT - Get Free Report) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 338,700 shares, an increase of 27.3% from the August 15th total of 266,100 shares. Approximately 0.6% of the company's shares are sold short. Based on an average daily trading volume, of 250,900 shares, the days-to-cover ratio is presently 1.3 days.

Cognyte Software (NASDAQ:CGNT) Shares Gap Up Following Insider Buying Activity

StockNews.com downgraded shares of Cognyte Software from a "strong-buy" rating to a "buy" rating in a research note on Wednesday.

Cognyte Software (NASDAQ:CGNT - Get Free Report) posted its earnings results on Tuesday. The medical device company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.07. The firm had revenue of $84.40 million for the quarter, compared to the consensus estimate of $83.69 million. Cognyte Software had a negative net margin of 3.70% and a negative return on equity of 5.94%. The company's revenue was up 9.5% on a year-over-year basis. During the same period last year, the firm posted ($0.11) EPS.

Needham & Company LLC reaffirmed a "hold" rating on shares of Cognyte Software in a report on Tuesday.

Cognyte Software (NASDAQ:CGNT) updated its FY25 earnings guidance. The company provided EPS guidance of $(0.03) for the period, compared to the consensus estimate of ($0.07). The company also issued revenue guidance of $340.1-$353.9 millionillion, compared to the consensus estimate of $343.40 millionillion.

Acadian Asset Management LLC raised its position in Cognyte Software Ltd. (NASDAQ:CGNT - Free Report) by 13.3% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 2,611,449 shares of the medical device company's stock after acquiring an additi

Cognyte Software (NASDAQ:CGNT) will be releasing earnings before the market opens on Tuesday, September 10, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=629162)

IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in shares of Cognyte Software Ltd. (NASDAQ:CGNT - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 76,706 shares of the medical device company's stock, valued at approximately $586

Cognyte Software Ltd. (NASDAQ:CGNT - Get Free Report) was the target of a large decrease in short interest in August. As of August 15th, there was short interest totalling 266,100 shares, a decrease of 42.0% from the July 31st total of 458,400 shares. Based on an average daily trading volume, of 222,900 shares, the short-interest ratio is currently 1.2 days. Approximately 0.4% of the company's stock are sold short.

ARK Investment Management LLC lowered its stake in Cognyte Software Ltd. (NASDAQ:CGNT - Free Report) by 9.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 331,485 shares of the medical device company's

Cognyte Software (NASDAQ:CGNT) Stock Passes Above Two Hundred Day Moving Average of $7.51

Cognyte Software Ltd. (NASDAQ:CGNT - Get Free Report) was the target of a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 458,400 shares, a decrease of 8.1% from the July 15th total of 498,800 shares. Based on an average trading volume of 218,300 shares, the short-interest ratio is currently 2.1 days. Currently, 0.7% of the company's stock are short sold.

Cognyte Software Ltd. (NASDAQ:CGNT - Get Free Report) saw a significant increase in short interest in July. As of July 15th, there was short interest totalling 498,800 shares, an increase of 24.8% from the June 30th total of 399,600 shares. Approximately 0.8% of the company's shares are short sold. Based on an average trading volume of 226,900 shares, the short-interest ratio is currently 2.2 days.

Acadian Asset Management LLC raised its holdings in shares of Cognyte Software Ltd. (NASDAQ:CGNT - Free Report) by 30.3% during the first quarter, according to its most recent filing with the SEC. The firm owned 2,304,970 shares of the medical device company's stock after purchasing an additional 5

Cognyte Software (NASDAQ:CGNT) Shares Cross Above Two Hundred Day Moving Average of $7.26

StockNews.com raised Cognyte Software from a "buy" rating to a "strong-buy" rating in a research report on Friday.

Cognyte Software (NASDAQ:CGNT) Shares Gap Down to $7.60

Needham & Company LLC reissued a "hold" rating on shares of Cognyte Software in a research note on Tuesday.

Cognyte Software (NASDAQ:CGNT) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.070--0.070 for the period, compared to the consensus estimate of -0.120. The company also issued revenue guidance of $337.1 millionillion-$350.9 millionillion, compared to the consensus estimate of $339.0 millionillion.

Cognyte Software (NASDAQ:CGNT) Hits New 1-Year High at $8.70